-
EP4155388
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4155388
| EP4155388 - FAT CELL HYPER-EXPRESSING FFAR4 AND USE THEREOF [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 13.10.2024 Database last updated on 19.10.2024 | |
| Former | Examination is in progress Status updated on 29.03.2024 | ||
| Former | Request for examination was made Status updated on 24.02.2023 | ||
| Former | The international publication has been made Status updated on 03.12.2021 | Most recent event Tooltip | 13.10.2024 | New entry: Communication of intention to grant a patent | Applicant(s) | For all designated states Numt Inc. 1-12-17, Hinode Kawasaki-ku Kawasaki-shi Kanagawa 210-0824 / JP | For all designated states Toho University 5-21-16, Omorinishi Ota-ku Tokyo 143-8540 / JP | [2023/13] | Inventor(s) | 01 /
TAKEI Yoshinori Tokyo 143-8540 / JP | 02 /
HIRASAWA Akira Uji-shi, Kyoto 611-0011 / JP | [2023/13] | Representative(s) | Dragotti & Associati S.R.L. Via Nino Bixio, 7 20129 Milano / IT | [N/P] |
| Former [2023/13] | Sonzogni, Laura Gabriella, et al Dragotti & Associati S.r.l. Via Nino Bixio, 7 20129 Milano / IT | Application number, filing date | 21814190.1 | 26.05.2021 | [2023/13] | WO2021JP20097 | Priority number, date | JP20200094495 | 29.05.2020 Original published format: JP 2020094495 | [2023/13] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021241659 | Date: | 02.12.2021 | Language: | JA | [2021/48] | Type: | A1 Application with search report | No.: | EP4155388 | Date: | 29.03.2023 | Language: | EN | [2023/13] | Search report(s) | International search report - published on: | JP | 02.12.2021 | (Supplementary) European search report - dispatched on: | EP | 13.10.2023 | Classification | IPC: | C12N5/077, A01K67/027, A61K35/28, A61K35/35, A61P3/10, A61P25/28, C12N5/10, C12N15/86 | [2023/13] | CPC: |
A61P3/10 (EP,US);
A61K38/177 (US);
A01K67/0275 (EP);
A61K35/28 (EP);
A61K35/35 (EP,US);
A61P25/28 (EP,US);
C12N15/86 (US);
C12N5/0653 (EP,US);
A01K2207/12 (EP);
A01K2217/05 (EP);
A01K2227/105 (EP);
A01K2267/0362 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/13] | Title | German: | FETTZELLEN-HYPEREXPRIMIERENDES FFAR4 UND VERWENDUNG DAVON | [2023/13] | English: | FAT CELL HYPER-EXPRESSING FFAR4 AND USE THEREOF | [2023/13] | French: | ADIPOCYTE HYPEREXPRIMANT FFAR4 ET SON UTILISATION | [2023/13] | Entry into regional phase | 21.12.2022 | Translation filed | 21.12.2022 | National basic fee paid | 21.12.2022 | Search fee paid | 21.12.2022 | Designation fee(s) paid | 21.12.2022 | Examination fee paid | Examination procedure | 21.12.2022 | Examination requested [2023/13] | 22.01.2024 | Amendment by applicant (claims and/or description) | 22.01.2024 | Date on which the examining division has become responsible | 03.04.2024 | Despatch of a communication from the examining division (Time limit: M04) | 14.06.2024 | Reply to a communication from the examining division | 14.10.2024 | Communication of intention to grant the patent | Fees paid | Renewal fee | 24.03.2023 | Renewal fee patent year 03 | 26.03.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO2007134613 (RHEOSCIENCE AS [DK], et al); | [Y]US2008004227 (HIRASAWA AKIRA [JP], et al); | International search | [X]WO2008139879 (PHARMAFRONTIER CO LTD [JP], et al) [X] 1-19 * [0003] *; | [X]WO2009038204 (PHARMA FRONTIER CO LTD [JP], et al) [X] 1-19 * 27 *; | [X]WO2009125804 (TAKEDA PHARMACEUTICAL [JP], et al) [X] 1-19 * [0 0 3 6], [0 0 5 3], [0058] *; | [X] - Ichimura, Atsuhiko, "Analyses of regulatory mechanism of energy homeostasis via free fatty acid receptors", (20180611), pages 1 - 6, Performance Report Kaken Kakenhi-Project-15H0562, URL: https://kaken.nii.ac.jp/ja/file/KAKENHI-PROJECT-15H05652/15H05652seika.pdf, XP009542814 [X] 1-19 * > * | by applicant | WO03106663 | WO2005083070 | JP2008001690 | JP2012520240 | JP2016214135 | JP2019137681 | - HIRASAWA, A. et al., Nat. Med., (20050000), vol. 11, pages 90 - 94 | - SUN, Q et al., Mol. Pharmacol., (20100000), vol. 78, pages 804 - 810 | - ICHIMURA, A. et al., Nature, (20120000), vol. 483, pages 350 - 354 | - HARA, T. et al., Rev Physiol Biochem Pharmacol., (20130000), vol. 164, pages 77 - 116 | - MILLIGAN, G. et al., Trends Pharmacol Sci., (20170000), vol. 38, pages 809 - 821 | - HARA, T. et al., Rev. Physiol. Biochem. Pharmacol., (20130000), vol. 164, pages 77 - 116 | - MILLIGAN, G. et al., Trend Pharmacol. Sci., (20170000), vol. 38, pages 809 - 821 | - HIRASAWA, A. et al., "Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120", Nat Med, (20050000), vol. 11, no. 1, doi:10.1038/nm1168, pages 90 - 94, XP055084999 DOI: http://dx.doi.org/10.1038/nm1168 | - AKKERMAN, S. et al., "Object recognition testing: methodological considerations on exploration and discrimination measures.", Behav Brain Res, (20120000), vol. 232, doi:10.1016/j.bbr.2012.03.022, pages 335 - 347, XP028514842 DOI: http://dx.doi.org/10.1016/j.bbr.2012.03.022 | - ANTUNES, M.BIALA, G., "The novel object recognition memory: neurobiology, test procedure, and its modifications.", Cogn Process, (20120000), vol. 13, doi:10.1007/s10339-011-0430-z, pages 93 - 110, XP035045688 DOI: http://dx.doi.org/10.1007/s10339-011-0430-z | - LEGER, M. et al., "Object recognition test in mice.", Nat Protoc, (20130000), vol. 8, doi:10.1038/nprot.2013.155, pages 2531 - 2537, XP037547556 DOI: http://dx.doi.org/10.1038/nprot.2013.155 |